US › Healthcare

Scorpius Holdings Inc (SCPX)

US · Healthcare · Biotechnology

$0.00+40.00%

Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue

$229,842

Revenue YoY

-78.0%

Net profit

$-984,429

Profit YoY

+89.5%

EPS

$-0.09

EPS estimate

$0.00

Net margin

-428.3%

Key statistics

Market cap

$30,571

Forward P/E

0.0

P/B

0.10

Book value

$-0.02

EPS (TTM)

$-4.18

52-week high

$0.04

52-week low

$0.00

50-day MA

$0.00

200-day MA

$0.00

Beta

-5.33

Analyst view

Analysts rate Scorpius Holdings Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $5.00.

Shareholding

Insiders

0.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Scorpius Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.